Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulation

Cancer Microenvironment

Volumn 4, Issue 3, 2011, Pages 351-360

  Edsparr, Karin ^a   Basse, Per H ^c   Goldfarb, Ronald H ^b   Albertsson, Per ^a,d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c Sopherion Therapeutics LLC   (United States)

^d FINSEN LABORATORY   (Denmark)

Author keywords

Cytotoxic lymphocyte; Matrix metalloproteinases; Natural killer cell; Proteases; T lymphocyte; Tumour infiltration

Indexed keywords

BATIMASTAT; COLLAGENASE 3; FOCAL ADHESION KINASE; GAMMA INTERFERON; GELATINASE A; GELATINASE B; HEPARANASE; ILOMASTAT; INTERLEUKIN 2; INTERSTITIAL COLLAGENASE; LAMIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; RANTES; STROMAL CELL DERIVED FACTOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE;

CD8+ T LYMPHOCYTE; CELL MIGRATION; CHEMOTAXIS; CYTOTOXIC T LYMPHOCYTE; ENZYME REGULATION; EXTRACELLULAR MATRIX; HUMAN; IMMUNOMODULATION; NATURAL KILLER CELL; NONHUMAN; OXIDATIVE STRESS; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

EID: 84856422630     PISSN: 18752292     EISSN: 18752284     Source Type: Journal    
DOI: 10.1007/s12307-010-0057-0     Document Type: Review

References (125)

1. Vaday GG, Lider O (2000) Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J Leukoc Biol 67:149-59
2. Owen CA, Campbell EJ (1999) The cell biology of leukocytemediated proteolysis. J Leukoc Biol 65:137-50
3. Albertsson P, Kim MH, Jonges LE et al (2000) Matrix metalloproteinases of human NK cells. In Vivo 14:269-76 (Pubitemid 30189238)
4. Goda S, Inoue H, Umehara H et al (2006) Matrix metalloproteinase-1 produced by human CXCL12-stimulated natural killer cells. Am J Pathol 169:445-58 (Pubitemid 44156307)
5. Ishida Y, Migita K, Izumi Y et al (2004) The role of IL-18 in the modulation of matrix metalloproteinases and migration of human natural killer (NK) cells. FEBS Lett 569:156-60 (Pubitemid 38844609)
6. Edsparr K, Speetjens FM, Mulder-Stapel A et al (2010) Effects of IL-2 on MMP expression in freshly isolated human NK cells and the IL-2 independent NK cell line YT. J Immunother 33(5):475-81
7. Kim MH, Kitson RP, Albertsson P et al (2000) Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors. J Immunol 164:5883-9 (Pubitemid 30389834)
8. Kitson RP, Appasamy PM, Nannmark U, Albertsson P, Gabauer MK, Goldfarb RH (1998) Matrix metalloproteinases produced by rat IL-2-activated NK cells. J Immunol 160:4248-53 (Pubitemid 28217279)
9. Zeng L, An S, Goetzl EJ (1996) Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor. Biochemistry 35:7159-64 (Pubitemid 26182107)
10. Kim MH, Albertsson P, Xue Y, Kitson RP, Nannmark U, Goldfarb RH (2000) Expression of matrix metalloproteinases and their inhibitors by rat NK cells: inhibition of their expression by genistein. In Vivo 14:557-64 (Pubitemid 34097516)
11. Chuang SS, Kim MH, Johnson LA et al (2000) 2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness. Immunology 100:378-83 (Pubitemid 30449953)
12. Kjaergaard J, HoklandM, Nannmark U, Hokland P, Basse P (1998) Infiltration patterns of short-and long-term cultured A-NK and T-LAK cells following adoptive immunotherapy. Scand J Immunol 47:532-40 (Pubitemid 28273362)
13. Sussman JJ, Parihar R, Winstead K, Finkelman FD (2004) Prolonged culture of vaccine-primed lymphocytes results in decreased antitumor killing and change in cytokine secretion. Cancer Res 64:9124-30 (Pubitemid 39665526)
14. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL (1995) T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 154:4379-89
15. Romanic AM, Madri JA (1994) The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J Cell Biol 125:1165-78 (Pubitemid 24177218)
16. Goetzl EJ, Banda MJ, Leppert D (1996) Matrix metalloproteinases in immunity. J Immunol 156:1-4 (Pubitemid 26006939)
17. Johnatty RN, Taub DD, Reeder SP et al (1997) Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 158:2327-33 (Pubitemid 127470018)
18. Weeks BS, Schnaper HW, Handy M, Holloway E, Kleinman HK (1993) Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B). J Cell Physiol 157:644-9 (Pubitemid 23361195)
19. Bar-Or A, Nuttall RK, Duddy M et al (2003) Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 126:2738-49 (Pubitemid 37463092)
20. Di Girolamo N, Tedla N, Lloyd A, Wakefield D (1998) Expression of matrix metalloproteinases by human plasma cells and B lymphocytes. Eur J Immunol 28:1773-84 (Pubitemid 28271693)
21. Trocme C, Gaudin P, Berthier S, Barro C, Zaoui P, Morel F (1998) Human B lymphocytes synthesize the 92-kDa gelatinase, matrix metalloproteinase-9. J Biol Chem 273:20677-84 (Pubitemid 28377640)
22. Dobaczewski M, Xia Y, Bujak M, Gonzalez-Quesada C, Frangogiannis NG (2010) CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol 176:2177-87
23. Leppert D, Hauser SL, Kishiyama JL, An S, Zeng L, Goetzl EJ (1995) Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids. Faseb J 9:1473-81
24. Xia M, Leppert D, Hauser SL et al (1996) Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol 156:160-7 (Pubitemid 26006959)
25. Zhou H, Bernhard EJ, Fox FE, Billings PC (1993) Induction of metalloproteinase activity in human T-lymphocytes. Biochim Biophys Acta 1177:174-8 (Pubitemid 23169572)
26. Leppert D, Waubant E, Burk MR, Oksenberg JR, Hauser SL (1996) Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Ann Neurol 40:846-52 (Pubitemid 27044602)
27. Stuve O, Dooley NP, Uhm JH et al (1996) Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol 40:853-63 (Pubitemid 27044603)
28. Montgomery AM, Sabzevari H, Reisfeld RA (1993) Production and regulation of gelatinase B by human T-cells. Biochim Biophys Acta 1176:265-8 (Pubitemid 23113768)
29. El-Shabrawi Y, Walch A, Hermann J, Egger G, Foster CS (2004) Inhibition of MMP-dependent chemotaxis and amelioration of experimental autoimmune uvei tis with a selective metalloproteinase-2 and -9 inhibitor. J Neuroimmunol 155:13-20 (Pubitemid 39165773)
30. Segarra M, Vilardell C, Matsumoto K et al (2005) Dual function of focal adhesion kinase in regulating integrin-induced MMP-2 and MMP-9 release by human T lymphoid cells. Faseb J 19:1875-7 (Pubitemid 41598780)
31. Owen JL, Iragavarapu-Charyulu V, Gunja-Smith Z, Herbert LM, Grosso JF, Lopez DM (2003) Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor. J Immunol 171:4340-51 (Pubitemid 37238712)
32. Zucker S, Hymowitz M, Conner CE, DiYanni EA, Cao J (2002) Rapid trafficking of membrane type 1-matrix metalloproteinase to the cell surface regulates progelatinase a activation. Lab Invest 82:1673-84 (Pubitemid 35462980)
33. Mollinedo F, Pulido R, Lacal PM, Sanchez-Madrid F (1991) Mobilization of gelatinase-rich granules as a regulatory mechanism of early functional responses in human neutrophils. Scand J Immunol 34:33-43
34. Owen CA, Hu Z, Lopez-Otin C, Shapiro SD (2004) Membranebound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinaseresistant collagenase and serpinase. J Immunol 172:7791-803 (Pubitemid 38747647)
35. Owen CA, Hu Z, Barrick B, Shapiro SD (2003) Inducible expression of tissue inhibitor of metalloproteinases-resistant matrix metalloproteinase-9 on the cell surface of neutrophils. Am J Respir Cell Mol Biol 29:283-94 (Pubitemid 37093986)
36. Brooks PC, Stromblad S, Sanders LC et al (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85:683-93 (Pubitemid 26181048)
37. Koyama Y, Naruo H, Yoshitomi Y et al (2008) Matrix metalloproteinase-9 associated with heparan sulphate chains of GPI-anchored cell surface proteoglycans mediates motility of murine colon adenocarcinoma cells. J Biochem 143:581-92 (Pubitemid 351670646)
38. Rolli M, Fransvea E, Pilch J, Saven A, Felding-Habermann B (2003) Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci U S A 100:9482-7 (Pubitemid 37033954)
39. Yu Q, Stamenkovic I (1999) Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13:35-48 (Pubitemid 29045114)
40. Yu WH, Woessner JF Jr (2000) Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem 275:4183-91 (Pubitemid 30094653)
41. Murphy G, Gavrilovic J (1999) Proteolysis and cell migration: creating a path? Curr Opin Cell Biol 11:614-21 (Pubitemid 29460404)
42. Curran S, Murray GI (1999) Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 189:300-8 (Pubitemid 29489213)
43. Polette M, Nawrocki-Raby B, Gilles C, Clavel C, Birembaut P (2004) Tumour invasion and matrix metalloproteinases. Crit Rev Oncol Hematol 49:179-86 (Pubitemid 38251350)
44. Al-Atrash G, Kitson RP, Xue Y, Goldfarb RH (2000) Cooperation of urokinase plasminogen activator and matrix metalloproteinases in NK cell invasion. In Vivo 14:565-70 (Pubitemid 34097517)
45. Kim MH, Albertsson P, Xue Y, Nannmark U, Kitson RP, Goldfarb RH (2001) Expression of neutrophil collagenase (MMP-8) in Jurkat T leukemia cells and its role in invasion. Anticancer Res 21:45-50 (Pubitemid 32267623)
46. Sodek KL, Brown TJ, Ringuette MJ (2008) Collagen I but not Matrigel matrices provide an MMP-dependent barrier to ovarian cancer cell penetration. BMC Cancer 8:223
47. Noel AC, Calle A, Emonard HP et al (1991) Invasion of reconstituted basement membrane matrix is not correlated to the malignant metastatic cell phenotype. Cancer Res 51:405-14
48. Butcher EC, Picker LJ (1996) Lymphocyte homing and homeostasis. Science 272:60-6 (Pubitemid 26110755)
49. Lammermann T, Bader BL, Monkley SJ et al (2008) Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 453:51-5 (Pubitemid 351630331)
50. Friedl P, Entschladen F, Conrad C, Niggemann B, Zanker KS (1998) CD4+ T lymphocytes migrating in three-dimensional collagen lattices lack focal adhesions and utilize beta1 integrinindependent strategies for polarization, interaction with collagen fibers and locomotion. Eur J Immunol 28:2331-43 (Pubitemid 28362708)
51. Friedl P, Brocker EB (2000) T cell migration in threedimensional extracellular matrix: guidance by polarity and sensations. Dev Immunol 7:249-66
52. Hauzenberger D, Klominek J, Bergstrom SE, Sundqvist KG (1995) T lymphocyte migration: the influence of interactions via adhesion molecules, the T cell receptor, and cytokines. Crit Rev Immunol 15:285-316 (Pubitemid 26259133)
53. Schmidt S, Friedl P (2009) Interstitial cell migration: integrindependent and alternative adhesion mechanisms. Cell Tissue Res 339(1):83-92
54. Friedl P, Wolf K (2010) Plasticity of cell migration: a multiscale tuning model. J Cell Biol 188:11-9
55. Lammermann T, Sixt M (2009) Mechanical modes of 'amoeboid' cell migration. Curr Opin Cell Biol 21:636-44
56. Basse PH, Nannmark U, Johansson BR, Herberman RB, Goldfarb RH (1991) Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells. J Natl Cancer Inst 83:944-50
57. Nannmark U, Johansson BR, Bryant JL et al (1995) Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy. Cancer Res 55:4627-32
58. Albertsson P, Basse PH, Edsparr K et al (2007) Differential locomotion of long-and short-term IL-2-activated murine natural killer cells in a model matrix environment. Scand J Immunol 66:402-9 (Pubitemid 47407600)
59. Edsparr K, Johansson BR, Goldfarb RH et al (2009) Human NK cell lines migrate differentially in vitro related to matrix interaction and MMP expression. Immunol Cell Biol 87(6):489-95
60. Toole BP, Biswas C, Gross J (1979) Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc Natl Acad Sci U S A 76:6299-303 (Pubitemid 10163388)
61. Pauli BU, Knudson W (1988) Tumor invasion: a consequence of destructive and compositional matrix alterations. Hum Pathol 19:628-39
62. Toole BP (1981) Glycosaminoglycans in morphogenesis. In: Hay ED (ed) Cell biology of the extracellular matrix. Plenum, New York, pp 259-94
63. Castermans K, Griffioen AW (2007) Tumor blood vessels, a difficult hurdle for infiltrating leukocytes. Biochim Biophys Acta 1776:160-74 (Pubitemid 350081058)
64. Fisher DT, Chen Q, Appenheimer MM et al (2006) Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy. Immunol Invest 35:251-77 (Pubitemid 44266776)
65. Wolf K, Muller R, Borgmann S, Brocker EB, Friedl P (2003) Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 102:3262-9 (Pubitemid 37314765)
66. Friedl P, Wolf K (2003) Proteolytic and non-proteolytic migration of tumour cells and leucocytes. Biochem Soc Symp 70:277-85 (Pubitemid 38497233)
67. Wolf K, Mazo I, Leung H et al (2003) Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160:267-77 (Pubitemid 36254960)
68. Sabeh F, Shimizu-Hirota R, Weiss SJ (2009) Protease-dependent versus -independent cancer cell invasion programs: threedimensional amoeboid movement revisited. J Cell Biol 185:11-9
69. Hagenaars M, Ensink NG, Basse PH et al (2000) The microscopic anatomy of experimental rat CC531 colon tumour metastases: consequences for immunotherapy? Clin Exp Metastasis 18:189-96 (Pubitemid 32165253)
70. Kuppen PJ, Basse PH, Goldfarb RH, Van De Velde CJ, Fleuren GJ, Eggermont AM (1994) The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats. Int J Cancer 56:574-9 (Pubitemid 24094410)
71. Kuppen PJ, van der Eb MM, Jonges LE et al (2001) Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer. Histochem Cell Biol 115:67-72 (Pubitemid 32202055)
72. Okada K, Nannmark U, Vujanovic NL et al (1996) Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer. Cancer Res 56:1599-608
73. Yang Q, Goding S, Hagenaars M et al (2006) Morphological appearance, content of extracellular matrix and vascular density of lung metastases predicts permissiveness to infiltration by adoptively transferred natural killer and T cells. Cancer Immunol Immunother 55:699-707
74. Yang Q, Hokland ME, Bryant JL et al (2003) Tumor-localization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of well-established lung metastases. Int J Cancer 105:512-9 (Pubitemid 36578556)
75. Albertsson PA, Basse PH, Hokland M et al (2003) NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity. Trends Immunol 24:603-9 (Pubitemid 37338529)
76. David L, Nesland JM, Holm R, Sobrinho-Simoes M (1994) Expression of laminin, collagen IV, fibronectin, and type IV collagenase in gastric carcinoma. An immunohistochemical study of 87 patients. Cancer 73:518-27 (Pubitemid 24046588)
77. Torimura T, Ueno T, Inuzuka S et al (1994) The extracellular matrix in hepatocellular carcinoma shows different localization patterns depending on the differentiation and the histological pattern of tumors: immunohistochemical analysis. J Hepatol 21:37-46 (Pubitemid 24236678)
78. Wolf K, Alexander S, Schacht Vet al (2009) Collagen-based cell migration models in vitro and in vivo. Semin Cell Dev Biol 20:931-41
79. Paget S (1989) The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev 8:98-101
80. Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274:21491-4
81. Jaaskelainen J, Maenpaa A, Patarroyo M et al (1992) Migration of recombinant IL-2-activated T and natural killer cells in the intercellular space of human H-2 glioma spheroids in vitro. A study on adhesion molecules involved. J Immunol 149:260-8
82. Katou F, Ohtani H, Watanabe Y, Nakayama T, Yoshie O, Hashimoto K (2007) Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer. Cancer Res 67:11195-201 (Pubitemid 350248544)
83. Reschner A, Hubert P, Delvenne P, Boniver J, Jacobs N (2008) Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response. Clin Exp Immunol 152:219-26 (Pubitemid 351520908)
84. Schulz R (2007) Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches. Annu Rev Pharmacol Toxicol 47:211-42
85. Hellstrand K (2003) Melanoma immunotherapy: a battle against radicals? Trends Immunol 24:232-3, author reply 4
86. Lardner A (2001) The effects of extracellular pH on immune function. J Leukoc Biol 69:522-30 (Pubitemid 32294836)
87. Ratner S (1992) Motility of IL-2-stimulated lymphocytes in neutral and acidified extracellular matrix. Cell Immunol 139:399-410
88. Bosco MC, Puppo M, Blengio F et al (2008) Monocytes and dendritic cells in a hypoxic environment: spotlights on chemotaxis and migration. Immunobiology 213:733-49
89. Zhao P, Li XG, Yang M et al (2008) Hypoxia suppresses the production of MMP-9 by human monocyte-derived dendritic cells and requires activation of adenosine receptor A2b via cAMP/PKA signaling pathway. Mol Immunol 45:2187-95
90. Rahat MA, Marom B, Bitterman H, Weiss-Cerem L, Kinarty A, Lahat N (2006) Hypoxia reduces the output of matrix metalloproteinase-9 (MMP-9) in monocytes by inhibiting its secretion and elevating membranal association. J Leukoc Biol 79:706-18 (Pubitemid 44835603)
91. Jodele S, Blavier L, Yoon JM, DeClerck YA (2006) Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev 25:35-43 (Pubitemid 43723980)
92. Mach F, Schonbeck U, Fabunmi RP et al (1999) T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation. Am J Pathol 154:229-38 (Pubitemid 29031630)
93. Miltenburg AM, Lacraz S, Welgus HG, Dayer JM (1995) Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts. J Immunol 154:2655-67
94. Aoudjit F, Esteve PO, Desrosiers M, Potworowski EF, St-Pierre Y (1997) Gelatinase B (MMP-9) production and expression by stromal cells in the normal and adult thymus and experimental thymic lymphoma. Int J Cancer 71:71-8 (Pubitemid 27158412)
95. Ganor Y, Grinberg I, Reis A, Cooper I, Goldstein RS, Levite M (2009) Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147/EMMPRIN, MMP-9 secretion and engraftment of Tleukemia in vivo. Leuk Lymphoma 50:985-97
96. Pistol G, Matache C, Calugaru A et al (2007) Roles of CD147 on T lymphocytes activation and MMP-9 secretion in systemic lupus erythematosus. J Cell Mol Med 11:339-48 (Pubitemid 46693332)
97. Mazar AP, Henkin J, Goldfarb RH (1999) The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis. Angiogenesis 3:15-32 (Pubitemid 129644777)
98. Carpen O, Saksela O, Saksela E (1986) Identification and localization of urokinase-type plasminogen activator in human NK-cells. Int J Cancer 38:355-60 (Pubitemid 16022317)
99. Goldfarb RH, Timonen T, Herberman RB (1984) Production of plasminogen activator by human natural killer cells. Large granular lymphocytes. J Exp Med 159:935-51 (Pubitemid 14159268)
100. Nykjaer A, Moller B, Todd RF 3rd et al (1994) Urokinase receptor. An activation antigen in human T lymphocytes. J Immunol 152:505-16 (Pubitemid 24072954)
101. Kramer MD, Spring H, Todd RF, Vettel U (1994) Urokinase-type plasminogen activator enhances invasion of human T cells (Jurkat) into a fibrin matrix. J Leukoc Biol 56:110-6 (Pubitemid 24270490)
102. Bianchi E, Ferrero E, Fazioli F et al (1996) Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. J Clin Invest 98:1133-41 (Pubitemid 26299926)
103. Gellert GC, Kitson RP, Goldfarb RH (2003) Urokinase-type plasminogen activator receptor crosslinking in an NK cell line increases integrin surface expression by the MAP kinase/ERK 1/2 signaling pathway. J Cell Biochem 89:279-88 (Pubitemid 36547262)
104. Gellert GC, Goldfarb RH, Kitson RP (2004) Physical association of uPAR with the alphaV integrin on the surface of human NK cells. Biochem Biophys Res Commun 315:1025-32 (Pubitemid 38249405)
105. Vlodavsky I, Eldor A, Haimovitz-Friedman A et al (1992) Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 12:112-27
106. Purushothaman A, Chen L, Yang Y, Sanderson RD (2008) Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma. J Biol Chem 283:32628-36
107. Zcharia E, Jia J, Zhang X et al (2009) Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases. PLoS One 4:e5181
108. O'Brien P, O'Connor BF (2008) Seprase: an overview of an important matrix serine protease. Biochim Biophys Acta 1784:1130-45
109. Bristow CL, Lyford LK, Stevens DP, Flood PM (1991) Elastase is a constituent product of T cells. Biochem Biophys Res Commun 181:232-9
110. Yamabe T, Takakura K, Sugie K et al (1997) Induction of the 2B9 antigen/dipeptidyl peptidase IV/CD26 on human natural killer cells by IL-2, IL-12 or IL-15. Immunology 91:151-8 (Pubitemid 27196013)
111. Sloane BF, Honn KV (1984) Cysteine proteinases and metastasis. Cancer Metastasis Rev 3:249-63
112. Gocheva V, Joyce JA (2007) Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle 6:60-4 (Pubitemid 46173882)
113. Thiele DL, Lipsky PE (1990) Mechanism of L-leucyl-L-leucine methyl ester-mediated killing of cytotoxic lymphocytes: dependence on a lysosomal thiol protease, dipeptidyl peptidase I, that is enriched in these cells. Proc Natl Acad Sci U S A 87:83-7
114. Wolters PJ, Laig-Webster M, Caughey GH (2000) Dipeptidyl peptidase I cleaves matrix-associated proteins and is expressed mainly by mast cells in normal dog airways. Am J Respir Cell Mol Biol 22:183-90 (Pubitemid 30351481)
115. Buzza MS, Zamurs L, Sun J et al (2005) Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin. J Biol Chem 280:23549-58 (Pubitemid 40884833)
116. Froelich CJ, Zhang X, Turbov J, Hudig D, Winkler U, Hanna WL (1993) Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes. J Immunol 151:7161-71 (Pubitemid 24001090)
117. Van Lint P, Libert C (2007) Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 82:1375-81 (Pubitemid 350276947)
118. Cauwe B, Van den Steen PE, Opdenakker G (2007) The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 42:113-85 (Pubitemid 46911962)
119. McCawley LJ, Matrisian LM (2001) Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 13:534-40 (Pubitemid 32817010)
120. Mott JD, Werb Z (2004) Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16:558-64 (Pubitemid 39201241)
121. Somasundaram R, Ruehl M, Tiling N et al (2000) Collagens serve as an extracellular store of bioactive interleukin 2. J Biol Chem 275:38170-5 (Pubitemid 32009134)
122. Opdenakker G, Van den Steen PE, Van Damme J, Gelatinase B (2001) a tuner and amplifier of immune functions. Trends Immunol 22:571-9
123. Gearing AJ, Beckett P, Christodoulou M et al (1995) Matrix metalloproteinases and processing of pro-TNF-alpha. J Leukoc Biol 57:774-7
124. Van Damme P, Vandekerckhove J, Gevaert K (2008) Disentanglement of protease substrate repertoires. Biol Chem 389:371-81 (Pubitemid 351773913)
125. Impens F, Colaert N, Helsens K et al (2010) MS-driven protease substrate degradomics. Proteomics 10:1284-96